We envision a future where diseases like cancer are curable. We believe that the proper combination of Artificial Intelligence, Bioinformatics and Biology translates into big discoveries. Our science aims to increase the response rates in immuno-oncology by investigating tumors, microbiome and immune system. We provide value as a service to our Life Science partners.
The microbiome has thousands of different functions and is treated by many scientists almost as a new, separate organ or even our second genome. We therefore witness a scientific revolution that may completely change the modern medicine and the definition of the human being. In the gut alone, the genes of these microorganisms outnumber the human ones by 150 to one. Tapping into the wealth of metagenomic information can accelerate the design of therapeutics and diagnostic tests.
We believe in a future where a new drug can be developed in one year. Adoption of Artificial intelligence solutions by pharmaceutical companies is the step forward towards a significant increase in speed and decrease of costs in the discovery process. It improves novelty of targets and compounds, increases the likelihood of success for existing compounds, and decreases experimental failure.
The unique strength of our team is the capability to provide a comprehensive solution to your problem. We effectively combine efforts of biologists, bioinformaticians, data scientists and software engineers to deliver value to all our collaborators.
Science projects providing reproducible research and software tools while staying lean and dynamic. We make bioinformatics workflows and software with human readable code, as well as machine learning models that "understand" biological data and provide cutting edge solutions and products for
“We’ve been delighted with the exceptional results Ardigen have delivered.”
“We’re extremely happy with Ardigen’s level of responsiveness, attention to details and overall technical insight.”
“Ardigen’s deep understanding of the complexities of molecular biology work flows and data has made them our partner of choice.”
“I’ve been really impressed with their expertise and communication skills. When we give them an analysis task, they go beyond what we’ve asked for and suggest and test new methods.”
Biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Biotechnology company developing novel immunotherapies.
Biopharmaceutical company focused on developing novel treatments for neurobehavioral disorders.
One of the biggest hospitals on the East Coast of the US
The third-oldest medical school in the United States, the graduate of Harvard University.
Biopharma company focused on novel approach to therapeutic discovery.
“The feedback I have from the Clinical team is that your resources are doing an excellent job.”
Company specializing in treatment of various cardiological and rheumatological conditions.
Leading science and technology company in healthcare, life science and performance materials.
Company focusing on novel treatments of metabolism, immunology, oncology and CNS related diseases.
The largest institution of higher learning in Poland’s northern region of Pomerania.
Originated in 1611 and officially opened in 1919, has been frequently listed as a top three university in the country.
A company developing analytic platforms to analyze DNA and other genome-related peptides and proteins.
To join us means to participate in our fight against cancer. Depending on your specialization, you may analyze multi-omics data, design and implement bioinformatics and AI solutions towards Precision Medicine. You will have an important impact on innovations in cancer diagnostics and treatments, one of the biggest challenges of contemporary medicine. Find out who we are currently looking for and how exactly you may grow with us!